Added to YB: 2025-09-25
Pitch date: 2025-09-23
GBT.PA [neutral]
Guerbet SA
-7.97%
current return
Author Info
Lux Opes Research covers European companies. Lots of them. Sign up for the newsletter.
Company Info
Guerbet SA engages in the development and marketing of contrast media products, delivery systems, medical devices, and related solutions.
Market Cap
EUR 177.0M
Pitch Price
EUR 14.56
Price Target
N/A
Dividend
N/A
EV/EBITDA
1.46
P/E
22.76
EV/Sales
0.15
Sector
Health Care Equipment and Supplies
Category
turnaround
Guerbet (GBT France): leadership change signals a reset after profit warning
GBT.PA (quick overview): French contrast agent leader in reset mode after profit warning & CEO change. CFO Jérôme Estampes interim CEO as board seeks permanent replacement. Core challenges: weak France trends, US distributor mix, operational setbacks. Dotarem/Elucirem products face regulatory pressure & competition. Transformation needed across industrial/commercial infrastructure. Leadership change potential catalyst but timing uncertain.
Read full article (1 min)